References
- Boumsell L., Bernard A., Lepage V., Degos L., Lemerle J., Daussert J. Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur. J. Immunol. 1978; 8: 900–904
- Royston I., Majoa J. A., Baird S. M., Meserve G. L., Griffiths J. C. Human T-cell antigens denned by monoclonal antibodies: The 65,000 dalton antigen of T cells (T65) is also found on chronic lymphocytic leukenia cells bearing surface immunoglobulin. J. Immunol. 1980; 125: 725–731
- Kamoun M., Kadin M. F., Martin P. J., Nettleton J., Hansen J. A. A novel T cell antigen preferentially expressed on mature T cells and also on (B-type) chronic lymphatic leukemic cells. J. Immunol. 1981; 127: 987–991
- Casali P., Burastero S. E., Nakamura M., Inghirami G., Notokin A. L. Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B cell subset. Science 1987; 26: 77–81
- Hardy R. R., Hayakawa K., Shimizu M., Yamasaki K., Kishimoto T. Rheumatoid factor secretion from human Leu-1 + B cells. Science 1987; 236: 81–86
- Bataille R., Klein B. CD5 positive B lymphocytes: A link between autoimmunity and B-cell oncogenesis. Anticancer Research 1988; 8: 707–710
- Drachman D. B., Kao I., Pestronk A., Toyka K. V. Myasthenia gravis as a receptor disorder. Ann. NY. Acad. Scie. 1976; 274: 226–234
- Lindstrom J. M., Seybold M., Lennon V. A., Whittingham S., Duane D. D. Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates and diagnostic value. Neurology 1976; 26: 1054–1059
- Ragheb S., Lisak R. P. The frequencies of CD5+ B lymphocytes in the peripheral blood of patients with myasthenia gravis. Neurology 1990; 40: 1120–1124
- Yi Q., Ahlberg R., Pirskanen R., Lefvert A. K. Levels of CD5+ B lymphocytes do not differ between patients with myasthenia gravis and healthy individuals. Neurology 1992; 42: 1081–1084
- Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invset. 1977; 21: 77–89
- Frochner S. C., Rafto S. Comparison of the subunits of Torpedo californica acetylcholine receptor by peptide mapping. Biochemistry 1979; 18: 301–307
- Msaon D. W., Penhale W. J., Sedgwick J. D. Preparation of lymphocyte subpopulation. Lymphocytes: a practical approach, C. C.B. Klaus. IRL Press, Oxford 1987; 48–52
- Walls E. V., Crawford D. H. Generation of human B lymphoblastoid cell lines using Epstein-Barr virus. Lymphocytes-a practical approach, G. Klaus. IRL press, Washington, DC 1987; 149–162
- Casali P., Prabhakar B. S., Notkins A. L. Characterization of multireactive autoantibodies and identification of LEU-1+ B lymphocytes as cells making antibodies binding multiple self and exogenous molecules. Int. Rev. Immunol 1988; 3: 17–45
- Casali P., Notkins A. L. Probing the human B-cell repertoire with EBV: Polyrcactive antibodies and CD5+ B lymphocytes. Ann. Rev. Immunol. 1989; 7: 513–535
- Kasaian M. T., Ikematsu H., Casali P. CD5+ B lymphocytes. Proc. Soc. Exp. Biol. Med. 1991; 197: 226–241
- Jasin H. E. The relationship between circulating CD5+ B lymphocytes and in vitro autoantibody synthesis in normal individuals. Cell. Immunol. 1991; 136: 133–141
- Lefvert A. K., Bergstrom K., Matell G., Osterman P. O., Pirskanen R. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathognetic implications. J. Neurol. Neurosurg. Psychiatry. 1978; 41: 394–405
- Tindall R. S. Humoral immunity in myasthenia gravis: clinical correlations of anti-receptor antibody avidity and titer. Ann. NY. Acad. Sci. 1981; 377: 316–331
- Hayakawa K., Hardy R. R., Herzenberg L. A. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J. Exp. Med. 1985; 161: 1554–1568
- Lennon V. A., Lindstrom J. M., Seybold M. E. Experimental autoimmune myasthenia gravis: cellular and humoral immune responses. Ann. NY. Acad. Sci. 1976; 274: 283–299
- Penn A. S., Rowland L. P. Myasthenia gravis. 7 ed. Merritt's textbook of Neurology, L. P. Rowland. Lea & Febiger, Philadelphia 1984; 561–567
- Suzuki N., Sakane T., Engleman E. G. Anti-DNA antibody prduction by CD5+ and CD5- B cells of patients with systemic lupus erythematosus. J. Clin. Invest. 1990; 85: 238–247
- Iwatani Y., Amino N., Hidaka Y., Kaneda T., Ichihara K., Tamaki H., Matsuzuka F., Fukata S., Kuma K., Miyai K. Decreases in alpha beta T cell receptor negative T cells and CD8 cells, and an increase in CD4+ CD8+ cells in active Hashimoto's disease and subacute thyroiditis. Clin. Exp. Immunol. 1992; 87: 444–449
- Kipps T. J., Vaugham J. H. Genetic influence on the levels of circulating CD5+ B lymphocytes. J. Immunol. 1987; 139: 1060–1064